Data on the in vitro and in vivo anti-tumor effects of itraconazole, paclitaxel, and the two in combination in HT-29 and YM-1 cancer cell line and HT-29 colon cancer xenograft models-Reference-Cited by-同舟云学术

Data on the in vitro and in vivo anti-tumor effects of itraconazole, paclitaxel, and the two in combination in HT-29 and YM-1 cancer cell line and HT-29 colon cancer xenograft models

Published:2021-04 Issue: Volume:35 Page:106862
ISSN:2352-3409
Container-title:Data in Brief
language:en
Short-container-title:Data in Brief

Author:

Ghadi Mahdi,Hosseinimehr Seyed Jalal,Talebpour Amiri Fereshteh,Mardanshahi Alireza,Noaparast Zohreh

Funder

Mazandaran University of Medical Sciences

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference10 articles.

1. An overview of cancer multidrug resistance: a still unsolved problem;Lage;Cell Mol. Life Sci.,2008

2. Itraconazole targets cell cycle heterogeneity in colorectal cancer;Buczacki;J. Exp. Med.,2018

3. Effect of NF-κB inhibitors on the chemotherapy-inducedapoptosis of the colon cancer cell line HT-29;LIU;Exp. Therap. Med.,2012

4. Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers;Guo;Drug Res. (Stuttg),2015

5. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576;Agrawal;Clin. Cancer Res.,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Commonly Used Stabilizers for Phytochemical-Based Nanoparticles: Stabilization Effects, Mechanisms, and Applications;Nutrients;2023-09-06

2. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen;Cancers;2022-05-23